✨ Fisheries and Health Notices
13 AUGUST NEW ZEALAND GAZETTE 2769
on the 11th of September 1997, No. 124, at page 2929 is hereby cancelled.
Dated at Wellington this 10th day of August 1998.
MARK EDWARDS, Policy Manager, Ministry of Fisheries (acting pursuant to delegated authority).
go5758
Health
Medicines Act 1981
Consent to the Distribution of a New Medicine
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Aciclovir 400 mg, 800 mg | Tablets | Lek Pharmaceutical and Chemical Company, Ljubljana, Slovenia | Alpha-Aciclovir |
| Azathioprine 50 mg | Tablet, film coated | Douglas Pharmaceuticals Limited, Lincoln, Auckland | Azamun |
| Miconazole 20 mg/mL | Spray, topical | Stephen Hunter Pty Limited, Ingleburn, New South Wales, Australia | Leuko Fungex |
| Miconazole 2% w/w | Powder, topical | DFC Thompson Australia Pty Limited, Thornleigh, New South Wales, Australia | Leuko Fungex |
| Miconazole 20 mg/g | Cream, topical | Stephen Hunter Pty Limited, Ingleburn, New South Wales, Australia | Leuko Fungex |
Dated this 6th day of August 1998.
G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.
go5766
Consent to the Distribution of Changed Medicines
Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto:
Schedule
| Name and Strength | Form | Name and Address of Manufacturer | Proprietary Name (if any) |
|---|---|---|---|
| Lacidipine 2 mg, 4 mg | Tablets, film coated | Glaxo Wellcome SA., Aranda de Duero, Spain and Glaxo Wellcome SpA., San Polo di Torrile, Parma, Italy | Lacipil |
| Egg-yolk phospholipid 1.2% w/v, glycerol 2.5% w/v, medium chain triglycerides 5% w/v, soya oil 5% w/v | Infusion, solution | B Braun Melsungen AG., Melsungen, Germany | Lipofundin MCT/LCT 10% |
| Egg-yolk phospholipid 1.2% w/v, glycerol 2.5% w/v, medium chain triglycerides 10% w/v, soya oil 10% w/v | Infusion, solution | B Braun Melsungen AG., Melsungen, Germany | Lipofundin MCT/LCT 20% |
| Pravastatin sodium 10 mg, 20 mg | Tablets | Bristol-Myers Squibb Australia Pty Limited, Noble Park, Victoria, Australia | Lipostat |
| Pink tablet: Ethinyloestradiol 20 µg, levonorgestrel 100 µg | Tablets, film coated | Ayerst-Wyeth Pharmaceuticals Inc., Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico | Loette |
| Green tablet: Lactose q.s. | |||
| Ethinyloestradiol 20 µg, levonorgestrel 100 µg | Tablet, film coated | Ayerst-Wyeth Pharmaceuticals Inc., Barrios Pozo Hondos & Jobos, Guayama, Puerto Rico | Loette 21 |
| Gabapentin 100 mg, 300 mg, 400 mg | Capsules, powder filled | Goedecke AG., Freiburg, Germany | Neurontin |
| Ranitidine bismuth citrate 400 mg | Tablet, film coated | Glaxo Wellcome Operations, Ware, Hertfordshire, United Kingdom | Pylorid |
Next Page →
PDF embedding disabled (Crown copyright)
View this page online at:
VUW Te Waharoa —
NZ Gazette 1998, No 112
NZLII —
NZ Gazette 1998, No 112
✨ LLM interpretation of page content
🌾 Cancellation of Fisheries Notice
🌾 Primary Industries & Resources10 August 1998
Fisheries, Notice Cancellation
- MARK EDWARDS, Policy Manager, Ministry of Fisheries
🏥 Consent to Distribution of New Medicines
🏥 Health & Social Welfare6 August 1998
Medicines, Distribution, Consent, New Medicines
- G. R. BOYD, Chief Advisor, Regulation and Safety
🏥 Consent to Distribution of Changed Medicines
🏥 Health & Social WelfareMedicines, Distribution, Consent, Changed Medicines